These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20599844)

  • 1. Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatment.
    Joosen MJ; van der Schans MJ; van Helden HP
    Chem Biol Interact; 2010 Oct; 188(1):255-63. PubMed ID: 20599844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats.
    Bloch-Shilderman E; Yacov G; Cohen L; Egoz I; Gutman H; Gez R; Rabinovitz I; Nili U
    Arch Toxicol; 2019 May; 93(5):1365-1384. PubMed ID: 30729277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
    van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
    Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
    Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
    Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and efficacy of atropine sulfate/obidoxime chloride co-formulation against VX in a guinea pig model.
    Kentrop J; Savransky V; Klaassen SD; van Groningen T; Bohnert S; Cornelissen AS; Cochrane L; Barry J; Joosen MJA
    Regul Toxicol Pharmacol; 2021 Feb; 119():104823. PubMed ID: 33212192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of reactivation test in anaesthetized dogs with experimental intoxication with nerve agents.
    Bajgar J; Fusek J; Bartosova L; Jun D; Kuca K
    J Appl Toxicol; 2006; 26(5):439-43. PubMed ID: 16915560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
    Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
    Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of therapeutic effect of obidoxime and dosing time in the acute intoxication by chlorfenvinphos in rats.
    Raszewski G; Filip R
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):37-45. PubMed ID: 19371264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
    Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
    Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
    Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
    Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX.
    Nambiar MP; Gordon RK; Rezk PE; Katos AM; Wajda NA; Moran TS; Steele KE; Doctor BP; Sciuto AM
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):142-50. PubMed ID: 17188727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig.
    Mumford H; Price ME; Cerasoli DM; Teschner W; Ehrlich H; Schwarz HP; Lenz DE
    Chem Biol Interact; 2010 Sep; 187(1-3):304-8. PubMed ID: 20176007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of threshold adverse effect doses of percutaneous VX exposure in African green monkeys.
    Genovese RF; Benton BJ; Oubre JL; Byers CE; Jakubowski EM; Mioduszewski RJ; Settle TJ; Steinbach TJ
    Toxicology; 2011 Jan; 279(1-3):65-72. PubMed ID: 20887765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
    Aurbek N; Thiermann H; Szinicz L; Worek F
    Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic use of localized cooling in the treatment of VX poisoning.
    Sawyer TW; Mikler J; Worek F; Reiter G; Thiermann H; Tenn C; Weatherby K; Bohnert S
    Toxicol Lett; 2011 Jul; 204(1):52-6. PubMed ID: 21530621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
    Mumford H; Price ME; Wetherell JR
    J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.